Encapsulation potential of a trypanocidal drug homidium bromide in bovine carrier erythrocytes
- 1 September 1985
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Die Gesamte Experimentelle Medizin
- Vol. 185 (5) , 345-353
- https://doi.org/10.1007/bf01851914
Abstract
Bovine red blood cells (RBC) were made to entrap homidium bromide, a trypanocidal drug. Hypotonic dialysis resulted in 0.3 mg drug encapsulated per milliliter of RBC. Homidium bromide had no untoward effects on the encapsulation of a marker14C-sucrose. However, RBC containing homidium bromide had a mean cell volume (MCV) larger than that of sham-loaded cells. EDTA did not reverse the effects of the drug on the MCV. The in vitro drug efflux rate was 0.097 mg/h. The effects of drug on the 24-h circulating survival was determined, and 24-h cell survival was reduced from 80% to 50%.This publication has 1 reference indexed in Scilit:
- Erythrocytes as carriers of chemotherapeutic agents for targeting the reticuloendothelial systemAmerican Journal of Hematology, 1980